Screener
Twist Bioscience Corporation TWST Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001581280-26-000040
| (In thousands, except per share data) | March 31,2026 | September 30,2025 |
|---|---|---|
| Total assets | $676,214 | $641,861 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $14,682 | $11,094 |
| Accrued compensation | 27,003 | 31,288 |
| Current portion of operating lease liability | 10,443 | 13,822 |
| Accrued expenses and other current liabilities | 67,848 | 35,202 |
| Total current liabilities | $119,976 | $91,406 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Twist Bioscience Corporation's accounts payable?
- Twist Bioscience Corporation (TWST) reported accounts payable of $14.68M in Q1 2026.
- How has Twist Bioscience Corporation's accounts payable changed year-over-year?
- Twist Bioscience Corporation's accounts payable increased by 82.1% year-over-year, from $8.06M to $14.68M.
- What is the long-term trend for Twist Bioscience Corporation's accounts payable?
- Over 4 years (2021 to 2025), Twist Bioscience Corporation's accounts payable has grown at a -7.1% compound annual growth rate (CAGR), from $14.9M to $11.09M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Twist Bioscience Corporation's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude